Gateway to the largest biotechnology sector in Australia

Find

Victorian Platform Technologies

Find Infrastructure

What's this

Victorian Biotech Companies & Providers

Advanced Search
What's this

Tax Incentives

Australia's new R&D Tax Credit makes Melbourne, Victoria one of the most attractive locations in the world for R&D.

The R&D Tax Credit replaces the R&D Tax Concession as Australia's principal initiative to support research and development.  The new tax credit will apply to income years beginning on or after 1 July 2011.

R&D Tax Credit for Companies with Turnover Less Than AUD$20 million.

Where a group’s annual turnover is less than $20 million, companies will be eligible for a 45% refundable credit, with no limit on the amount of expenditure claimable under this program. This is a significant increase from the existing limit of $5 million and the abolishment of a cap.

R&D Tax Credit for Companies with Turnover Greater Than AUD$20 million.

Where group turnover is over $20 million, companies will be eligible for a 40% non-refundable credit, equivalent to a 133% tax concession, one-third higher than the current basic rate of support.

Further, companies conducting R&D in Australia where intellectual property rights are held offshore (as for the current international premium R&D concession) will also be able to access this credit.

What is the difference between a refundable and non-refundable tax offset?

Tax offsets are applied directly to a company's income tax liability to reduce the amount of a tax they have to pay.

The 45% R&D Tax Credit will be a refundable tax offset, which means that if a company's tax liability is reduced to zero, companies may be entitled to a refund of any unused offset amount.

The 40% R&D Tax Credit will be a non-refundable tax offset, which means that companies cannot access a refund for any unused offset amount if their liability has been reduced to zero.  However any excess offsets may be carried forward for use in future income years.

Links

Innovation Australia is an independent statutory body established to assist with the administration of the Australian Government's innovation and venture capital programs, including administration of the R&D Tax Credit.

 

 

What's Happening?

8th May BioBreakfast - The Technological and Economic Opportunities of BioBanking in Australia

Tuesday 8th May, 7:15am - 9:00am
Cinema 1, Australian Centre for the Moving Image (ACMI), Federation Square, Melbourne

As the pharmaceutical industry and the wider research sector shifts rapidly towards personalised medicine and genomics combined with the increasing power of computational sciences, biobanking is clearly an emerging winner in terms of commercialisation opportunity and provision of quality research services for the future.

More news and events